Practical Guide

How Research Peptides Are Made: Synthesis, HPLC, and Mass Spectrometry

The chemistry behind solid-phase peptide synthesis and the analytical methods that verify what is in the vial.

|April 4, 2026|9 min read

From Amino Acids to Sequence

A peptide is, fundamentally, a chain of amino acids linked by peptide bonds. Making one from scratch means choosing the amino acids, ordering them correctly, and forming each bond without damaging the chain. That sounds simple. In practice, the chemistry is delicate, and modern peptide production is the result of decades of refinement.

The dominant method for synthesizing research peptides today is solid-phase peptide synthesis (SPPS), originally developed by Bruce Merrifield in the early 1960s. The approach earned Merrifield the 1984 Nobel Prize in Chemistry and transformed peptide research from a niche pursuit into a routine laboratory technique.

How Solid-Phase Synthesis Works

SPPS anchors the growing peptide chain to a solid resin bead. Each amino acid is added one at a time, in reverse order — from the C-terminus to the N-terminus. The basic cycle for each amino acid:

  1. 1.Deprotection. The N-terminus of the last added amino acid is protected with a chemical group (typically Fmoc — fluorenylmethyloxycarbonyl). Treatment with piperidine removes this group, exposing a reactive amino group.
  1. 1.Coupling. The next amino acid, with its N-terminus protected and its carboxyl group activated by a coupling reagent (HBTU, HATU, or DIC are common), is added. The activated carboxyl forms a peptide bond with the exposed amino group on the growing chain.
  1. 1.Washing. Excess reagents and byproducts are washed away. The resin keeps the peptide chain in place.
  1. 1.Repeat. The cycle is repeated until the full sequence is assembled.
  1. 1.Cleavage. The completed peptide is cleaved from the resin using trifluoroacetic acid (TFA), which also removes any remaining side-chain protecting groups.

For a 15-amino-acid peptide like BPC-157, this means roughly 15 coupling cycles. For longer peptides — semaglutide is 31 residues, tirzepatide is 39 — the cycle count grows accordingly, and so do the opportunities for error.

Where Errors Come From

No coupling step is 100% efficient. Real-world coupling yields are typically 99-99.5% per step. That sounds high, but errors compound across many cycles. A 99% per-step yield over 40 cycles produces about 67% theoretical full-length peptide. The rest is shorter "deletion sequences" missing one or more residues.

Other common errors:

  • Racemization — an amino acid's stereochemistry flips during coupling, producing a D-isomer instead of the desired L-isomer
  • Aspartimide formation — aspartic acid residues can undergo side reactions producing aspartimide byproducts
  • Oxidation — methionine and cysteine residues are susceptible to oxidation during synthesis or storage
  • Incomplete deprotection — protecting groups left in place produce truncated or modified sequences

The crude product after SPPS is therefore not pure peptide — it is a mixture containing the intended sequence plus various impurities. Purification and analysis are essential.

Purification: Where HPLC Earns Its Keep

High-Performance Liquid Chromatography (HPLC) is the workhorse purification and analysis technique in peptide chemistry.

The principle is straightforward. A peptide mixture is dissolved and pumped through a column packed with a stationary phase — typically silica beads coated with a hydrophobic material (C18 is most common). A liquid solvent gradient pushes the mixture through the column. Different peptide species interact with the stationary phase differently based on their hydrophobicity, so they exit the column at different times.

The output is a chromatogram — a graph of detector signal versus time. Each peak represents a distinct molecular species. A pure peptide shows one dominant peak. A mixture shows multiple peaks.

For preparative HPLC, fractions corresponding to the desired peak are collected, concentrated, and lyophilized. The resulting peptide is then re-analyzed by HPLC to confirm purity.

Research-grade peptides typically demonstrate purity of 98% or higher on HPLC analysis. A 98% pure peptide means that 98% of the mass in the sample corresponds to the intended sequence, with the remaining 2% being a mixture of deletion sequences, racemized residues, oxidized byproducts, and other impurities.

Mass Spectrometry: Confirming Identity

HPLC tells you a sample is mostly one thing. Mass spectrometry (MS) tells you what that one thing is.

The principle: a peptide is ionized — typically by electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) — and accelerated through an electric field. The mass-to-charge ratio of the ions is measured, and from that the molecular weight is calculated.

For peptide verification, the measured molecular weight is compared to the theoretical molecular weight calculated from the amino acid sequence. A match within typical tolerance (0.5-1.0 Da depending on instrument resolution) confirms the intended sequence was produced.

More advanced MS techniques — particularly tandem mass spectrometry (MS/MS) — can fragment the peptide and read the amino acid sequence directly, providing definitive confirmation of identity.

What a Quality Certificate Should Include

When evaluating a peptide for research use, a credible Certificate of Analysis (COA) should include:

  • HPLC chromatogram with the area-under-curve quantification of the main peak and any impurities
  • Mass spectrometry data showing the measured molecular weight
  • Calculated theoretical molecular weight for comparison
  • Peptide content (mass of pure peptide in the vial, adjusted for the salt and water content of the lyophilized cake)
  • Net peptide content if reported separately
  • Date of analysis and lot number

Third-party analysis — performed by an independent laboratory rather than the manufacturer's in-house lab — represents the gold standard. The principle is the same as financial auditing: an independent party with no incentive to overstate quality.

Common Quality Pitfalls

A few real-world issues that even good-looking COAs can mask:

Net vs. gross peptide content. A vial labeled "10 mg" might contain 10 mg of total mass, but only 7-8 mg of actual peptide — the remainder being TFA salt and water. Net peptide content is the relevant number for dosing calculations.

Outdated COAs. A COA from synthesis lot A says nothing about what is in your vial from lot B. Match lot numbers.

Selective reporting. Some manufacturers report only HPLC purity without mass spec confirmation. This tells you the sample is one main thing, but not that the one main thing is what was advertised.

Endotoxin contamination. HPLC and MS do not detect bacterial endotoxins. For research applications where endotoxin matters, separate testing (LAL assay) is required.

A Brief Note on Synthesis Tier

Not all SPPS is equivalent. The peptide market broadly includes:

  • Research-grade synthesis — 98%+ purity, third-party tested, intended for preclinical research applications
  • GMP synthesis — produced under Good Manufacturing Practice for clinical research or pharmaceutical use; substantially more expensive and tightly regulated
  • Bulk crude synthesis — lower purity, lower cost, suitable only for screening applications

The difference is not whether the chemistry was performed correctly, but the degree of purification, quality control, and regulatory oversight applied to the output.

Note

This article is intended for informational and educational purposes only. It does not constitute medical advice.

Sources1 peer-reviewed

  1. 1.Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current pharmaceutical design (2011). PMID 21548867
synthesis
quality
hplc
mass-spectrometry
purity

Related Compounds

Still have questions?

ASK AXIOM ABOUT THIS TOPIC →